[Taylor&Francis] Efficacy and safety of anti-CLDN18.2 therapies in advanced or metastatic gastric, gastro-oesophageal junction, and oesophageal carcinomas with CLDN18.2 positivity: a systematic review and meta-analysis

SHADS Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-27 09:55
Reward30points

journalㄩFuture Oncology

AuthorsㄩYaping Zhang; Shangbin Kao; Dian Li; Canlong Yan; Biao Huang; Hongming Fang

Published dateㄩ2026-5-15

DOIㄩ10.1080/14796694.2026.2659354

PDF linkㄩhttps://www.tandfonline.com/doi/pdf/10.1080/14796694.2026.2659354

Article linkㄩhttps://doi.org/10.1080/14796694.2026.2659354

Article SourceㄩInforma UK Limited


Remarkㄩ
Reply

Use magic Donate Report

All Reply1 Show all posts
aellie Post time 2 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Return to the list